•
Jun 30, 2019

Lexicon Pharmaceuticals Q2 2019 Earnings Report

Total Revenue
$9.68M
Previous year: $13.8M
-29.6%
EPS
-$0.22
Previous year: -$0.33
-33.3%
Research and development expenses
$12.6M
Selling, general and admin expenses
$14.3M
Gross Profit
$8.36M
Cash and Equivalents
$11.1M
Free Cash Flow
-$26.9M
Total Assets
$233M

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income